Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ACTL6A antisense RNA 1 (ACTL6A-AS1)
- Target
- ACTL6A-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Antisense RNA
01
Overview
ACTL6A antisense RNA 1 (ACTL6A-AS1) is a long non-coding RNA (lncRNA) transcribed from the DNA strand antisense to the ACTL6A gene. As an antisense RNA, it may regulate the expression of the ACTL6A gene or related loci, acting through hybridization-dependent interference, chromatin modulation, or other mechanisms commonly associated with lncRNAs. Although there is no direct literature on ACTL6A-AS1’s bioactivity or therapeutic relevance, analogous antisense lncRNAs can influence cancer progression, differentiation, or gene silencing. Existing evidence for the broader class supports a regulatory role in gene expression and chromatin structure, especially in cancer and developmental biology contexts[5][6].
02
Mechanism of action
Not applicable for drugs, but antisense RNAs may modulate target mRNA stability, splicing, or translation and other regulatory effects[5][6].
03
Biological functions
Regulation of gene expression (by antisense mechanism in cis or trans)Chromatin organization (likely, inferred from general antisense RNA function and functional analogy with other ACTL6A-interacting lncRNAs)Epigenetic regulation
04
Disease associations
Other (Potential roles in cancer and cell differentiation, but not directly established for ACTL6A-AS1; other antisense RNAs are implicated in cancer[5][6].)
Beyond the preview
Go deeper on ACTL6A antisense RNA 1 (ACTL6A-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ACTL6A antisense RNA 1 (ACTL6A-AS1).